Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-6bf8c574d5-mggfc Total loading time: 0 Render date: 2025-03-01T06:58:10.752Z Has data issue: false hasContentIssue false

Chapter 29 - Iron Storage Disorders in Children

from Section IV - Metabolic Liver Disease

Published online by Cambridge University Press:  19 January 2021

By
Sarah A. Taylor ,
Michael R. Narkewicz  and
Cara L. Mack
Edited by
Frederick J. Suchy ,
Ronald J. Sokol  and
William F. Balistreri
Edited in association with
Jorge A. Bezerra ,
Cara L. Mack  and
Benjamin L. Shneider
Frederick J. Suchy
Affiliation:
University of Colorado, Children’s Hospital Colorado, Aurora
Ronald J. Sokol
Affiliation:
University of Colorado, Children’s Hospital Colorado, Aurora
William F. Balistreri
Affiliation:
Cincinnati Children’s Hospital Medical Center, Cincinnati
Jorge A. Bezerra
Affiliation:
Cincinnati Children’s Hospital Medical Center, Cincinnati
Cara L. Mack
Affiliation:
University of Colorado, Children’s Hospital Colorado, Aurora
Benjamin L. Shneider
Affiliation:
Texas Children’s Hospital, Houston
Get access

Summary

Iron overload states can be classified as primary or secondary. There are many disorders that can lead to iron overload (Table 29.1) [1, 2]. This chapter focuses on hereditary hemochromatosis (HH), juvenile hemochromatosis (JHH), and secondary iron overload (primarily transfusion associated) in the pediatric patient and in neonatal hemochromatosis (NH).

Type
Chapter
Information
Liver Disease in Children , pp. 515 - 529
Publisher: Cambridge University Press
Print publication year: 2021

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Pietrangelo, A, Caleffi, A, Corradini, E. Non-HFE hepatic iron overload. Semin Liver Dis 2011;31:302–18.Google Scholar
Bacon, BR, Adams, PC, Kowdley, DV, et al. Diagnosis and Management of Hemochromatosis: 2011 Practice Guideline by the AASLD. Hepatology 2011;54(1):328–43.CrossRefGoogle Scholar
Evstatiev, R, Gasche, C. Iron sensing and signalling. Gut 2012;61:933–52.Google Scholar
Vaulont, S, Lou, DQ, Viatte, L, Kahn, A. Of mice and men: the iron age. J Clin Invest 2005;115:2079–82.CrossRefGoogle ScholarPubMed
De Domenico, I, Ward, DM, Kaplan, J. Hepcidin and ferroportin: the new players in iron metabolism. Semin Liver Dis 2011;31:272–9.Google Scholar
Pietrangelo, A. Hepcidin in human iron disorders: therapeutic implications. J Hepatol 2011;54:173–81.Google Scholar
Huang, FW, Pinkus, JL, Pinkus, GS, Fleming, MD, Andrews, NC. A mouse model of juvenile hemochromatosis. J Clin Invest 2005;115:2187–91.CrossRefGoogle ScholarPubMed
Feder, JN, Gnirke, A, Thomas, W, et al. A novel MHC class I-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet 1996;13:399–408.CrossRefGoogle ScholarPubMed
Pietrangelo, A. Genetics, genetic testing, and management of hemochromatosis: 15 years since hepcidin. Gastroenterology 2015;149:1240–51.CrossRefGoogle ScholarPubMed
Phatak, PD, Sham, RL, Raubertas, RF, et al. Prevalence of hereditary hemochromatosis in 16031 primary care patients. Ann Intern Med 1998;129:954–61.Google Scholar
Olynyk, JK, Cullen, DJ, Aquilia, S, et al. A population-based study of the clinical expression of the hemochromatosis gene. N Engl J Med 1999;341:718–24.Google Scholar
Edwards, CQ, Griffen, LM, Goldgar, D, et al. Prevalence of hemochromatosis among 11,065 presumably healthy blood donors. N Engl J Med 1988;318:1355–62.CrossRefGoogle Scholar
Ramrakhiani, S, Bacon, R. Hemochromatosis: advances in molecular genetics and clinical diagnosis. J Clin Gastroenterol 1998;27:41–6.CrossRefGoogle ScholarPubMed
Sandu, K, Flintoff, K, Chatfield, MD, et al. Phenotypic analysis of hemochromatosis subtypes reveals variations in severity of iron overload and clinical disease. Blood 2018;132(1):101–10.Google Scholar
Kong, X, Xie, L, Zhu, H. Genotypic and phenotypic spectra of hemojuvelin mutations in primary hemochromatosis patients: a systematic review. Orphanet J Rare Dis 2019;14:2–24.Google Scholar
Adams, PC, Kertesz, AE, Valberg, LS. Screening for hemochromatosis in children of homozygotes: prevalence and cost-effectiveness. Hepatology 1995;22:1720–7.Google Scholar
Grove, J, Daly, AK, Burt, AD, et al. Heterozygotes for HFE mutations have no increased risk of advanced alcoholic liver disease. Gut 1998;43:262–6.Google Scholar
Bonkovsky, HL, Jawaid, Q, Tortorelli, K, et al. Non-alcoholic steatohepatitis and iron: increased prevalence of mutations of the HFE gene in non-alcoholic steatohepatitis. J Hepatol 1999;31:421–9.CrossRefGoogle ScholarPubMed
Kowdley, KV, Trainer, TD, Saltzman, JR, et al. Utility of hepatic iron index in American patients with hereditary hemochromatosis: a multicenter study. Gastroenterology 1997;113:1270–7.Google Scholar
Martin, DR, Semelka, RC. Magnetic resonance imaging of the liver: review of techniques and approach to common diseases. Semin Ultrasound CT MR 2005;26:116–31.CrossRefGoogle ScholarPubMed
Adams, PC. Implications of genotyping of spouses to limit investigation of children in genetic hemochromatosis. Clin Genet 1998;53:176–8.Google Scholar
Guyader, D, Jacquelinet, C, Moirand, R, et al. Noninvasive prediction of fibrosis in C282Y homozygous hemochromatosis. Gastroenterology 1998;115:929–36.Google Scholar
Whitlock, EP, Garlitz, BA, Harris, EL, Beil, TL, Smith, PR. Screening for hereditary hemochromatosis: a systematic review for the US Preventive Services Task Force. Ann Intern Med 2006;145:209–23.CrossRefGoogle Scholar
Niederau, C, Erhardt, A, Haussinger, D, et al. Haemochromatosis and the liver. J Hepatol 1999;30(Suppl 1):6–11.Google Scholar
EASL. Clinical practice guidelines for HFE hemochromatosis. J Hepatol 2010;53:3–22.CrossRefGoogle Scholar
Gehrke, SG, Pietrangelo, A, Kascak, M, et al. HJV gene mutations in European patients with juvenile hemochromatosis. Clin Genet 2005;67:425–8.Google Scholar
Wolfe, L, Olivieri, N, Sallan, D, et al. Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major. N Engl J Med 1985;312:1600–3.Google Scholar
Nielsen, P, Fischer, R, Engelhardt, R et al. Liver iron stores in patients with secondary haemosiderosis under iron chelation therapy with deferoxamine or deferiprone. Br J Haematol 1995;91:827–33.CrossRefGoogle ScholarPubMed
Hernando, D, Levin, YS, Sirlin, CB, Reeder, SB. Quantification of liver iron with MRI: state of the art and remaining challenges. J Magn Reson Imaging 2014;40:1003–21.Google Scholar
Brittenham, GM, Griffith, PM, Nienhuis, AW, et al. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 1994;331:567–73.Google Scholar
Cabibbo, S, Fidone, C, Garozzo, G, et al. Chronic red blood cell exchange to prevent clinical complications in sickle cell disease. Transfus Apher Sci 2005;32:315–21.Google Scholar
Shah, NR. Advances in iron chelation therapy: transitioning to a new oral formulation. Drugs Context 2017;6:212502.Google Scholar
Cappellini, MD, Musallam, KM, Taher, AT. Overview of iron chelation therapy with desferrioxamine and deferiprone. Hemoglobin 2009;33(Suppl1):S58–S69.Google Scholar
Knisely, AS, Mieli-Vergani, G, Whitington, PF. Neonatal hemochromatosis. Gastroenterol Clin North Am 2003;32:877–89, vi–vii.Google Scholar
Kelly, AL, Lunt, PW, Rodrigues, F, et al. Classification and genetic features of neonatal haemochromatosis: a study of 27 affected pedigrees and molecular analysis of genes implicated in iron metabolism. J Med Genet 2001;38:599–610.Google Scholar
Taylor, SA, Kelly, S, Alonso, EM, Whitington, PF. The effects of gestational alloimmune liver disease on fetal and infant morbidity and mortality. J Pediatr 2018;196:123–8.Google Scholar
Whitington, PF. Gestational alloimmune liver disease and neonatal hemochromatosis. Semin Liver Dis 2012;32:325–32.Google ScholarPubMed
Pan, X, Kelly, S, Melin-Aldana, H, Malladi, P, Whitington, PF. Novel mechanism of fetal hepatocyte injury in congenital alloimmune hepatitis involves the terminal complement cascade. Hepatology 2010;51:2061–8.Google Scholar
Hoftman, AC, Hernandez, MI, Lee, KW, Stiehm, ER. Newborn illnesses caused by transplacental antibodies. Adv Pediatr 2008;55:271–304.CrossRefGoogle ScholarPubMed
Bonilla, S, Prozialeck, JD, Malladi, P, et al. Neonatal iron overload and tissue siderosis due to gestational alloimmune liver disease. J Hepatol 2012;56:1351–5.Google Scholar
Bonilla, SF, Melin-Aldana, H, Whitington, PF. Relationship of proximal renal tubular dysgenesis and fetal liver injury in neonatal hemochromatosis. Pediatr Res 2010;67:188–93.CrossRefGoogle ScholarPubMed
Whitington, PF, Pan, X, Kelly, S, Melin-Aldana, H, Malladi, P. Gestational alloimmune liver disease in cases of fetal death. J Pediatr 2011;159:612–16.CrossRefGoogle ScholarPubMed
Silver, MM, Beverley, DW, Valberg, LS, et al. Perinatal hemochromatosis. Clinical, morphologic, and quantitative iron studies. Am J Pathol 1987;128: 538–54.Google Scholar
Ekong, UD, Kelly, S, Whitington, PF. Disparate clinical presentation of neonatal hemochromatosis in twins. Pediatrics 2005;116:e880–e884.Google Scholar
Taylor, SA, Whitington, PF. Neonatal acute liver failure. Liver Transpl 2016;22:677–85.Google Scholar
Knisely, AS, O’Shea, PA, Stocks, JF, Dimmick, JE. Oropharyngeal and upper respiratory tract mucosal-gland siderosis in neonatal hemochromatosis: an approach to biopsy diagnosis. J Pediatr 1988;113:871–4.Google Scholar
Udell, IW, Barshes, NR, Voloyiannis, T, et al. Neonatal hemochromatosis: radiographical and histological signs. Liver Transplant 2005;11:998–1000.Google Scholar
Leonis, MA, Balistreri, WF. Neonatal hemochromatosis: it’s OK to say “NO” to antioxidant-chelator therapy. Liver Transplant 2005;11:1323–5.Google Scholar
Rand, EB, Karpen, SJ, Kelly, S, et al. Treatment of neonatal hemochromatosis with exchange transfusion and intravenous immunoglobulin. J Pediatr 2009;155:566–71.Google Scholar
Ekong, UD, Melin-Aldana, H, Whitington, PF. Regression of severe fibrotic liver disease in 2 children with neonatal hemochromatosis. J Pediatr Gastroenterol Nutr 2008;46:329–33.Google Scholar
Grabhorn, E, Richter, A, Burdelski, M, Rogiers, X, Ganschow, R. Neonatal hemochromatosis: long-term experience with favorable outcome. Pediatrics 2006;118:2060–5.Google Scholar
Rodrigues, F, Kallas, M, Nash, R, et al. Neonatal hemochromatosis: medical treatment vs. transplantation: the King’s experience. Liver Transplant 2005;11:1417–24.Google Scholar
Sundaram, SS, Alonso, EM, Whitington, PF. Liver transplantation in neonates. Liver Transplant 2003;9:783–8.Google Scholar
Sheflin-Findling, S, Annunziato, RA, Chu, J, et al. Liver transplantation for neonatal hemochromatosis: analysis of the UNOS database. Pediatr Transplantation 2015;19:164–9.CrossRefGoogle ScholarPubMed
Whitington, PF, Kelly, S, Taylor, SA, et al. Antenatal treatment with intravenous immunoglobulin to prevent gestational alloimmune liver disease: comparative effectiveness of 14-week versus 18-week initiation. Fetal Diagn Ther 2018;43:218–25.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure no-reply@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×